Asia-Pacific Digital PCR Market: Focus on Application, End User, and Country Analysis - Analysis and Forecast, 2024-2034
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 7-10 working days.Introduction to Asia-Pacific Digital PCR Market
The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.
Market Introduction
The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.
Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.
The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.
Market Segmentation:
Segmentation 1: by Application
Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.
Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
This report will be delivered in 7-10 working days.Introduction to Asia-Pacific Digital PCR Market
The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.
Market Introduction
The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.
Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.
The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.
Market Segmentation:
Segmentation 1: by Application
- Clinical and Research Application
- Environmental Application
- Other Application
- Academic and Research Institutes
- Hospitals and Clinics
- Diagnostic Centers
- Pharmaceutical and Biopharmaceutical Companies
- Other End User
- China
- Japan
- South Korea
- Australia
- Rest-of-Asia-Pacific
Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.
Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
- RevoSketch Inc.
- JN Medsys
- Sysmex Corporation
Executive Summary
Scope and Definition
1 MARKETS
1.1 Market Overview
1.1.1 Workflow of Digital PCR
1.1.2 Comparison of qPCR and dPCR
1.2 Trends: Current and Future Impact Assessment
1.2.1 Integration with Next-Generation Sequencing (NGS)
1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
1.2.3 Increasing Product Launches in d-PCR Ecosystem
1.3 Supply Chain Overview
1.4 Research and Development Review
1.4.1 Patent Filing Trend (by Region)
1.4.2 Patent Filing Trend (by Country)
1.4.3 Patent Filing Trend (by Year)
1.5 Ongoing Digital PCR Clinical Trials
1.6 Regulatory Landscape
1.6.1 Asia Pacific
1.6.1.1 Japan
1.6.1.2 China
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
1.7.1.2 Increasing Incidence of Infectious Diseases
1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
1.7.2 Market Restraints
1.7.2.1 High Cost of Platforms Associated with Digital-PCR
1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
1.7.3 Market Opportunities
1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
1.7.3.2 Growing Adoption of dPCR in Emerging Markets
2 REGIONS
2.1 Regional Summary
2.2 Drivers and Restraints
2.3 Asia-Pacific
2.3.1 Regional Overview
2.3.2 Driving Factors for Market Growth
2.3.3 Factors Challenging the Market
2.3.4 Application
2.3.5 By End User
2.3.6 China
2.3.7 Australia
2.3.8 South Korea
2.3.9 Japan
2.3.10 Rest-of-Asia-Pacific
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Landscape
3.2 Market Share Analysis
3.3 Company Profile
3.3.1 Genetron Holdings Limited
3.3.1.1 Overview
3.3.1.2 Top Products/Product Portfolio
3.3.1.3 Top Competitors
3.3.1.4 Target Customers
3.3.1.5 Key Personnel
3.3.1.6 Analyst View
3.3.2 RevoSketch Inc.
3.3.2.1 Overview
3.3.2.2 Top Products/Product Portfolio
3.3.2.3 Top Competitors
3.3.2.4 Target Customers
3.3.2.5 Key Personnel
3.3.2.6 Analyst View
3.3.3 JN Medsys
3.3.3.1 Overview
3.3.3.2 Top Products/Product Portfolio
3.3.3.3 Top Competitors
3.3.3.4 Target Customers
3.3.3.5 Key Personnel
3.3.3.6 Analyst View
3.3.4 Sysmex Corporation.
3.3.4.1 Overview
3.3.4.2 Top Products/Product Portfolio
3.3.4.3 Top Competitors
3.3.4.4 Target Customers
3.3.4.5 Key Personnel
3.3.4.6 Analyst View
4 RESEARCH METHODOLOGY
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast
Scope and Definition
1 MARKETS
1.1 Market Overview
1.1.1 Workflow of Digital PCR
1.1.2 Comparison of qPCR and dPCR
1.2 Trends: Current and Future Impact Assessment
1.2.1 Integration with Next-Generation Sequencing (NGS)
1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
1.2.3 Increasing Product Launches in d-PCR Ecosystem
1.3 Supply Chain Overview
1.4 Research and Development Review
1.4.1 Patent Filing Trend (by Region)
1.4.2 Patent Filing Trend (by Country)
1.4.3 Patent Filing Trend (by Year)
1.5 Ongoing Digital PCR Clinical Trials
1.6 Regulatory Landscape
1.6.1 Asia Pacific
1.6.1.1 Japan
1.6.1.2 China
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
1.7.1.2 Increasing Incidence of Infectious Diseases
1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
1.7.2 Market Restraints
1.7.2.1 High Cost of Platforms Associated with Digital-PCR
1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
1.7.3 Market Opportunities
1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
1.7.3.2 Growing Adoption of dPCR in Emerging Markets
2 REGIONS
2.1 Regional Summary
2.2 Drivers and Restraints
2.3 Asia-Pacific
2.3.1 Regional Overview
2.3.2 Driving Factors for Market Growth
2.3.3 Factors Challenging the Market
2.3.4 Application
2.3.5 By End User
2.3.6 China
2.3.7 Australia
2.3.8 South Korea
2.3.9 Japan
2.3.10 Rest-of-Asia-Pacific
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Landscape
3.2 Market Share Analysis
3.3 Company Profile
3.3.1 Genetron Holdings Limited
3.3.1.1 Overview
3.3.1.2 Top Products/Product Portfolio
3.3.1.3 Top Competitors
3.3.1.4 Target Customers
3.3.1.5 Key Personnel
3.3.1.6 Analyst View
3.3.2 RevoSketch Inc.
3.3.2.1 Overview
3.3.2.2 Top Products/Product Portfolio
3.3.2.3 Top Competitors
3.3.2.4 Target Customers
3.3.2.5 Key Personnel
3.3.2.6 Analyst View
3.3.3 JN Medsys
3.3.3.1 Overview
3.3.3.2 Top Products/Product Portfolio
3.3.3.3 Top Competitors
3.3.3.4 Target Customers
3.3.3.5 Key Personnel
3.3.3.6 Analyst View
3.3.4 Sysmex Corporation.
3.3.4.1 Overview
3.3.4.2 Top Products/Product Portfolio
3.3.4.3 Top Competitors
3.3.4.4 Target Customers
3.3.4.5 Key Personnel
3.3.4.6 Analyst View
4 RESEARCH METHODOLOGY
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast
LIST OF FIGURES
Figure 1: Asia-Pacific Digital PCR Market (by Application), $Million 202, 2029 and 2034
Figure 2: Asia-Pacific Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
Figure 3: Key Events to Keep Track of in the Digital PCR Market
Figure 4: Supply Chain and Risks within the Supply Chain
Figure 5: Digital PCR Market (by Region), January 2020-September 2024
Figure 6: Digital PCR Market (by Country), January 2020-September 2024
Figure 7: Digital PCR Market (by Year), January 2020-September 2024
Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
Figure 9: China Digital PCR Market, $Million, 2023-2034
Figure 10: Australia Digital PCR Market, $Million, 2023-2034
Figure 11: South Korea Digital PCR Market, $Million, 2023-2034
Figure 12: Japan Digital PCR Market, $Million, 2023-2034
Figure 13: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
Figure 14: Strategic Initiatives, January 2019-September 2024
Figure 15: Share of Strategic Initiatives, January 2019-September 2024
Figure 16: Data Triangulation
Figure 17: Top-Down and Bottom-Up Approach (Segment-Wise Analysis)
Figure 18: Assumptions and Limitations
Figure 1: Asia-Pacific Digital PCR Market (by Application), $Million 202, 2029 and 2034
Figure 2: Asia-Pacific Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
Figure 3: Key Events to Keep Track of in the Digital PCR Market
Figure 4: Supply Chain and Risks within the Supply Chain
Figure 5: Digital PCR Market (by Region), January 2020-September 2024
Figure 6: Digital PCR Market (by Country), January 2020-September 2024
Figure 7: Digital PCR Market (by Year), January 2020-September 2024
Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
Figure 9: China Digital PCR Market, $Million, 2023-2034
Figure 10: Australia Digital PCR Market, $Million, 2023-2034
Figure 11: South Korea Digital PCR Market, $Million, 2023-2034
Figure 12: Japan Digital PCR Market, $Million, 2023-2034
Figure 13: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
Figure 14: Strategic Initiatives, January 2019-September 2024
Figure 15: Share of Strategic Initiatives, January 2019-September 2024
Figure 16: Data Triangulation
Figure 17: Top-Down and Bottom-Up Approach (Segment-Wise Analysis)
Figure 18: Assumptions and Limitations
LIST OF TABLES
Table 1: Market Snapshot
Table 2: Opportunities across Regions
Table 3: Comparison of qPCR and dPCR
Table 4: Digital PCR Market, Trend Analysis
Table 5: Digital PCR Market, Recent Product Launches
Table 6: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
Table 7: Regulatory Framework
Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 10: Digital PCR Market (by Region), $Million, 2023-2034
Table 11: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 12: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
Table 13: China Digital PCR Market (by Application), $Million, 2023-2034
Table 14: China Digital PCR Market (by End User), $Million, 2023-2034
Table 15: Australia Digital PCR Market (by Application), $Million, 2023-2034
Table 16: Australia Digital PCR Market (by End User), $Million, 2023-2034
Table 17: South Korea Digital PCR Market (by Application), $Million, 2023-2034
Table 18: South Korea Digital PCR Market (by End User), $Million, 2023-2034
Table 19: Japan Digital PCR Market (by Application), $Million, 2023-2034
Table 20: Japan Digital PCR Market (by End User), $Million, 2023-2034
Table 21: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 22: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
Table 1: Market Snapshot
Table 2: Opportunities across Regions
Table 3: Comparison of qPCR and dPCR
Table 4: Digital PCR Market, Trend Analysis
Table 5: Digital PCR Market, Recent Product Launches
Table 6: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
Table 7: Regulatory Framework
Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 10: Digital PCR Market (by Region), $Million, 2023-2034
Table 11: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 12: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
Table 13: China Digital PCR Market (by Application), $Million, 2023-2034
Table 14: China Digital PCR Market (by End User), $Million, 2023-2034
Table 15: Australia Digital PCR Market (by Application), $Million, 2023-2034
Table 16: Australia Digital PCR Market (by End User), $Million, 2023-2034
Table 17: South Korea Digital PCR Market (by Application), $Million, 2023-2034
Table 18: South Korea Digital PCR Market (by End User), $Million, 2023-2034
Table 19: Japan Digital PCR Market (by Application), $Million, 2023-2034
Table 20: Japan Digital PCR Market (by End User), $Million, 2023-2034
Table 21: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 22: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
